Auditory Brainstem Implant Market Scope And Analysis

  • Report Code : TIPRE00035303
  • Category : Life Sciences
  • No. of Pages : 200
Buy Now

Auditory Brainstem Implant Market Analysis Report 2021 to 2022

Buy Now


Auditory Brainstem Implant Market Report Scope

Report Attribute Details
Market size in 2022 US$ 61.19 Million
Market Size by 2030 US$ 114.67 Million
Global CAGR (2022 - 2030) 8.2%
Historical Data 2020-2022
Forecast period 2022-2030
Segments Covered By Component
  • Microphone
  • Decoding Chip
  • Electrodes
By Age Group
  • Adults and Pediatric
By Application
  • Sensorineural Hearing Loss and Conductive Hearing Loss
By End User
  • Hospitals
  • ENT Clinics
  • Ambulatory Surgical Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Cochlear Limited
  • Med EL Oticon Medical
  • Zhejiang Nurotron Biotechnology Co Ltd
  • Sonova Holding AG
  • Key development by major market player include:

    • In January 2022, Cochlear Americas Corporation received FDA approval for its Nucleus 24 Cochlear Implant System. This approval broadens the usage of this device for individuals aged five years and above who have severe to profound hearing loss in one ear [also known as single-sided deafness/unilateral hearing loss (SSD/UHL)] and normal hearing or mild hearing loss in the other ear.